%0 Journal Article %T Case Report of Exposure to Voriconazole in the Second and Third Trimesters of Pregnancy %+ Université Paris Descartes - Paris 5 (UPD5) %+ CHU Necker - Enfants Malades [AP-HP] %+ Service des Maladies infectieuses et tropicales [CHU Necker] %+ Centre d'infectiologie Necker-Pasteur [CHU Necker] %+ Imagine - Institut des maladies génétiques (IMAGINE - U1163) %+ Centre Hospitalier Victor Dupouy %+ Institut Pasteur [Paris] (IP) %A Tehrani, M, Shoai %A Sicre de Fontbrune, F. %A Roth, P. %A Allisy, C. %A Bougnoux, M.-E %A Hermine, O. %A Lecuit, M. %A Lortholary, O. %A Charlier, C. %< avec comité de lecture %@ 0066-4804 %J Antimicrobial Agents and Chemotherapy %I American Society for Microbiology %V 57 %N 2 %P 1094-1095 %8 2013-01-22 %D 2013 %R 10.1128/AAC.00899-12 %M 23165463 %Z Life Sciences [q-bio] %Z Life Sciences [q-bio]/Human health and pathology %Z Life Sciences [q-bio]/Human health and pathology/Infectious diseases %Z Life Sciences [q-bio]/Microbiology and Parasitology %Z Life Sciences [q-bio]/Microbiology and Parasitology/MycologyJournal articles %X Azoles, such as voriconazole, are contraindicated during pregnancy because of fetal toxicity. We report the case of a pregnant woman with invasive aspergillosis who received voriconazole without a maternofetal adverse effect [...] %G English %L pasteur-02924795 %U https://pasteur.hal.science/pasteur-02924795 %~ PASTEUR %~ UNIV-PARIS5 %~ APHP %~ CHU-UNIV-PARIS5 %~ UNIV-PARIS %~ UP-SANTE